SCHEMBL9583148

SCHEMBL9583148

CCCC=CCCC(=O)OCC(COC(=O)CCC=CCCC)OCn1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 1/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ BLM P54132 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ LMNA P02545 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ VCP P55072 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ HIF1A Q16665 1/20 0.60
▸ HBB P68871 2/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ PNP P00491 4/20 0.49
▸ USP2 O75604 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ EDNRA P25101 1/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9582655 0.96 PDE3A (0.67) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9583221 0.91 MEN1 (0.67) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9583513 0.90 PDE3A (0.57) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9584119 0.90 PDE3A (0.57) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9583707 0.89 MEN1 (0.64) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9583020 0.88 PDE3A (0.55) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9584156 0.88 MEN1 (0.63) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9582899 0.88 PDE3A (0.57) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9584235 0.87 MEN1 (0.62) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9583116 0.87 MEN1 (0.62) PDE3AMEN1KMT2ABLMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback